INVE Technologies, Inc.
For the period ended Dec 31, 2024. Filed Mar 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 17, 2025
INVE$2.60+2.0%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except par value)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $135,646 | $23,312 |
| Restricted cash | 300 | 1,072 |
| Accounts receivable, net of allowances of $655 and $1,610 as of December 31, 2024 and 2023, respectively | 4,214 | 7,174 |
| Inventories | 7,475 | 12,649 |
| Prepaid expenses and other current assets | 5,210 | 2,170 |
| Current assets held-for-sale | — | 33,109 |
| Total current assets | 152,845 | 79,486 |
| Property and equipment, net | 7,694 | 8,472 |
| Operating lease right-of-use assets | 2,000 | 2,289 |
| Other assets | 686 | 678 |
| Non-current assets held-for-sale | — | 18,798 |
| Total assets | $163,225 | $109,723 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $2,746 | $5,445 |
| Financial liabilities, net of debt issuance costs of $0 and $51 as of December 31, 2024 and 2023, respectively | — | 9,949 |
| Operating lease liabilities | 852 | 782 |
| Accrued compensation and related benefits | 862 | 1,376 |
| Accrued income taxes payable | 1,173 | 104 |
| Other accrued expenses and liabilities | 2,327 | 917 |
| Current liabilities held-for-sale | — | 12,209 |
| Total current liabilities | 7,960 | 30,782 |
| Long-term operating lease liabilities | 1,167 | 1,507 |
| Other long-term liabilities | 29 | 26 |
| Non-current liabilities held-for-sale | — | 3,136 |
| Total liabilities | 9,156 | 35,451 |
| Commitments and contingencies (see Note 16) | ||
| Stockholders' equity: | ||
| Stockholders' equity: | ||
| Series B preferred stock, $0.001 par value: 5,000 shares authorized; 5,000 shares issued and outstanding as of December 31, 2024 and 2023, respectively | 5 | 5 |
| Common stock, $0.001 par value: 50,000 shares authorized; 25,974 and 24,902 shares issued and 23,431 and 23,247 shares outstanding as of December 31, 2024 and 2023, respectively | 26 | 25 |
| Additional paid-in capital | 509,482 | 500,752 |
| Treasury stock 2,543 and 1,655 shares as of December 31, 2024 and 2023, respectively | (16,490) | (12,969) |
| Accumulated deficit | (340,050) | (414,870) |
| Accumulated other comprehensive income | 1,096 | 1,329 |
| Total stockholders' equity | 154,069 | 74,272 |
| Total liabilities and stockholders' equity | $163,225 | $109,723 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.